Podcast
Should Neutral Trials Change Practice - Lessons from HFpEF
  • Detail & Program Access
  • Overview & Objectives
  • Credit Eligibility
  • Faculty
  • Funding Support
CLICK HERE TO LISTEN

Program Access and Details:

Program Length:
25 minutes

Resources:
Audio recording

Credits:
This program is not accredited. Physicians may earn self-learning credits through active steps. View more information under the Credit Eligibility tab.

program advertising tile
CLICK HERE TO LISTEN

Program Access and Details:

Program Length:
25 minutes

Resources:
Audio recording

Credits:
This program is not accredited. Physicians may earn self-learning credits through active steps. View more information under the Credit Eligibility tab.

program advertising tile

This program was developed by the Canadian Collaborative Research Network.

Program Description:

Heart failure with preserved EF (HFpEF) carries substantial morbidity and mortality, yet evidence-based treatments to improve outcomes are sorely lacking. Recently, the FDA made the unusual decision to approve sacubitril/valsartan for HFpEF despite a neutral trial with this agent. Similarly, while spironolactone’s major trial in HFpEF was not positive, guidelines have endorsed this therapy based on sub-group analyses. This podcast will explore why these decisions were made and whether these treatments should be considered for HFpEF patients.

 

Learning Objectives:

  • To review current treatment strategies for HFpEF
  • To understand how neutral trials may still influence guidelines and practice

 

This program is NOT accredited.

Mainpro+ participants may earn certified credits by completing a Linking Learning Exercise.

Specialist participants may claim Section 2 credits (up to 2 credits per hour) following completion of a personal learning project (PLP) under Section 2: Self-Learning Activities within the MAINPORT ePortfolio. 

Milan Gupta
MD, FRCPC, FCCS, CPC(HC)
Brampton, ON
Narendra Singh
MD, FRCPC, FCCS, FACC, FAHA
Atlanta, GA

This program was developed by the Canadian Collaborative Research Network, a not-for-profit physician organization.  No outside funding support was received for this program. 

© 2020-2021 MDLearn, All Rights are Reserved